Advanced Statistics in Regulatory Critical Clinical Initiatives Advanced Statistics in Regulatory Critical Clinical Initiatives
Chapman & Hall/CRC Biostatistics Series

Advanced Statistics in Regulatory Critical Clinical Initiatives

Wei Zhang and Others
    • $69.99
    • $69.99

Publisher Description

Advanced Statistics in Regulatory Critical Clinical Initiatives is focused on the critical clinical initiatives introduced by the 21st Century Cure Act passed by the United States Congress in December 2016. The book covers everything from the outline of the initiatives to analysis on the effect on biopharmaceutical research and development. Advanced Statistics in Regulatory Critical Clinical Initiatives provides innovative ways to resolve common challenges in statistical research of rare diseases such small sample sizes and provides guidance for combined use of data. With analysis from regulatory and scientific perspectives this book is an ideal companion for researchers in biostatistics, pharmaceutical development, and policy makers in related fields.

Key Features: Provides better understanding of innovative design and analysis of each critical clinical initiatives which may be used in regulatory review/approval of drug development. Makes recommendations to evaluate submissions accurately and reliably. Proposes innovative study designs and statistical methods for oncology and/or rare disease drug development. Provides insight regarding current regulatory guidance on drug development such as gene therapy and rare diseases.

GENRE
Science & Nature
RELEASED
2022
May 25
LANGUAGE
EN
English
LENGTH
317
Pages
PUBLISHER
CRC Press
SELLER
Taylor & Francis Group
SIZE
5
MB
The Ancient Ship The Ancient Ship
2009
Biorenewable Solvents for Organic Synthesis Biorenewable Solvents for Organic Synthesis
2024
Space-Air-Ground Integrated Network Security Space-Air-Ground Integrated Network Security
2023
Satellit über Tiananmen Satellit über Tiananmen
2022
Assessing Digital Literacy Assessing Digital Literacy
2021
Distributed Energy Management of Electrical Power Systems Distributed Energy Management of Electrical Power Systems
2020
Medical Risk Prediction Models Medical Risk Prediction Models
2021
Real-World Evidence in Drug Development and Evaluation Real-World Evidence in Drug Development and Evaluation
2021
Biomarker Analysis in Clinical Trials with R Biomarker Analysis in Clinical Trials with R
2020
Biosimilar Clinical Development: Scientific Considerations and New Methodologies Biosimilar Clinical Development: Scientific Considerations and New Methodologies
2016
Innovative Methods for Rare Disease Drug Development Innovative Methods for Rare Disease Drug Development
2020
Statistical Design, Monitoring, and Analysis of Clinical Trials Statistical Design, Monitoring, and Analysis of Clinical Trials
2021